Showing 3771-3780 of 6035 results for "".
- Aerie Pharmaceuticals Announces Agreement to Acquire Avizorex Pharma to Advance Its Dry Eye Programhttps://modernod.com/news/aerie-pharmaceuticals-announces-agreement-to-acquire-avizorex-pharma-to-advance-its-dry-eye-program/2477097/Aerie Pharmaceuticals announced it is acquiring Avizorex Pharma, a Spanish ophthalmic pharmaceutical company developing therapeutics for the treatment of dry eye disease. AVX completed a phase 2a study in dry eye subjects earlier this year with its lead product candidate, AVX-012. The acti
- Extreme Dry Eye Left Fox News’ Shannon Bream Suicidal Until She Found Hope in Treatmenthttps://modernod.com/news/extreme-dry-eye-left-fox-news-shannon-bream-suicidal-until-she-found-hope-in-treatment/2477095/Anchor Shannon Bream struggled with extreme pain and could barely sleep until she found hope in treatment, according to a article in
- Solving a Medical Mystery Crucial to Future Space Travelhttps://modernod.com/news/solving-a-medical-mystery-crucial-to-future-space-travel/2477089/Astronauts often wrestle with blurry vision during spaceflight and this problem is jeopardizing longer missions to Mars, according to a report in Medscape. Half of the astronauts on the International Space Station have already expe
- Bloomberg: Allergan CEO’s Best Career Decision Was Taking a ‘Huge’ Pay Cuthttps://modernod.com/news/bloomberg-allergan-ceos-best-career-decision-was-taking-a-huge-pay-cut/2477083/Allergan Chief Executive Officer Brent Saunders told Bloomberg News that one of the most important career moves he ev
- Optina Diagnostics and Wagner Macula Retina Center to Conduct a Study to Identify the Causes of Memory Loss Through Eye Diagnosticshttps://modernod.com/news/optina-diagnostics-and-wagner-macula-retina-center-will-collaborate-to-conduct-a-clinical-study-to-identify-the-causes-of-memory-loss-through-eye-diagnostics/2477076/Optina Diagnostics and Wagner Macula Retina Center are entering into a collaboration agreement to conduct a clinical study for the advancement of Optina’s Retinal Deep Phenotyping platform. This collaboration will lay the groundwork for Optina’s future pivotal clinical trial. &
- Integrated Clinical Trial Analyses Further Substantiate that Teprotumumab Significantly Improves Debilitating Effects of Thyroid Eye Diseasehttps://modernod.com/news/integrated-clinical-trial-analyses-further-substantiate-that-teprotumumab-significantly-improves-debilitating-effects-of-thyroid-eye-disease/2477063/Horizon Therapeutics announced integrated, pooled efficacy data from the phase 2 and phase 3 clinical trials of teprotumumab for the treatment of active thyroid eye disease (TED) compared to placebo. The results support prior analyses of significant reductions in inflammation, proptosis (eye bulg
- Johnson & Johnson Vision Releases Data From Study of Acuvue Oasys With Transitions Light Intelligent Technologyhttps://modernod.com/news/johnson-johnson-vision-releases-data-from-study-of-acuvue-oasys-with-transitions-light-intelligent-technology/2477034/Johnson & Johnson Vision announced new data from a study of its Acuvue Oasys with Transitions Light Intelligent Technology, which found the benefits of these first-of-its-kind light adaptive contact lens were deemed highly valued and useful by people who had never w
- Sight Sciences: International MIGS Study Confirms Long-Term Safety and Efficacy of the OMNI Surgical System Predicate Device (VISCO360)https://modernod.com/news/sight-sciences-international-migs-study-confirms-long-term-safety-and-efficacy-of-the-omni-surgical-system-predicate-device-visco360/2477032/Sight Sciences announced a new, single center study of glaucoma surgery patients published in the July 2019 issue of Clinical Ophthalmology, which shows that ab-interno microcatheterization and 360˚ viscodilation of Schlemm’s Canal using one of the OMNI
- IDx Taps Former LabCorp Executive to Lead Sales and Customer Successhttps://modernod.com/news/idx-taps-former-labcorp-executive-to-lead-sales-and-customer-success/2477030/IDx Technologies announced that it has appointed former LabCorp executive Seth Rainford as President of Global Markets. In his newly created role, Mr. Rainford will be charged with expanding market opportunities and driving operational excellence at IDx. “Se
- CooperVision Shares Latest Contact Lens Research Results in Paper and Poster Presentations at Academy 2019https://modernod.com/news/coopervision-shares-latest-contact-lens-research-results-in-paper-and-poster-presentations-at-academy-2019/2477027/CooperVision clinicians and research partners are among the hundreds of presenters lined up to report their scientific advancements this week at Academy 2019 in Orlando. The latest company and company-sponsored research will be summarized in a series of papers and posters that encompass the compa